Company InfoNewsInvestor InformationResearchDevelopmentCareersBusiness DevelopmentResourcesDrugs databaseBack to the home pageSearch  
Drugs database
Drugs A-Z

Brands A-Z

Drugs by categories

Drugs by manufacturer

Drugs by packager

Antibiotics for sale

Online Viagra bestellen in Nederland

Home / Drugs / Starting with M / Magnesium 		 
Magnesium
  

Magnesium hydroxide is used primarily in "Milk of Magnesia", a white aqueous, mildly alkaline suspension of magnesium hydroxide formulated at about 8%w/v. Milk of magnesia is primarily used to alleviate constipation, but can also be used to relieve indigestion and heartburn. When taken internally by mouth as a laxative, the osmotic force of the magnesia suspension acts to draw fluids from the body and to retain those already within the lumen of the intestine, serving to distend the bowel, thus stimulating nerves within the colon wall, inducing peristalsis and resulting in evacuation of colonic contents.
PackagersAmerican Regent
American Therapeutics Medicines Inc.
Bioniche Pharma
Claris Lifesciences Inc.
DSM Corp.
Luitpold Pharmaceuticals Inc.
Mallinckrodt Baker Inc.
McGuff Co. Inc.
Merit Pharmaceuticals
Pekana Naturheilmittel GmbH
Torrance Co.
United Guardian Inc.

drug interactions

Alendronate: Formation of non-absorbable complexes

Amprenavir: The antiacid decreases the absorption of amprenavir

Atazanavir: This gastric pH modifier decreases the levels/effects of atazanavir

Chloroquine: The antiacid decreases the absorption of chloroquine

Ciprofloxacin: Formation of non-absorbable complexes

Clodronate: Formation of non-absorbable complexes

Dapsone: Formation of non-absorbable complexes

Delavirdine: Magnesium antacids may decrease the absorption of delavirdine.

Demeclocycline: Formation of non-absorbable complexes

Dihydroquinidine barbiturate: The antiacid decreases the absorption of quinidine

Doxycycline: Formation of non-absorbable complexes

Enoxacin: Formation of non-absorbable complexes

Etidronic acid: Formation of non-absorbable complexes

Fosamprenavir: The antiacid decreases the absorption of amprenavir

Gatifloxacin: Formation of non-absorbable complexes

Gemifloxacin: Formation of non-absorbable complexes

Grepafloxacin: Magnesium may decrease the absorption of grepafloxacin. Doses should be spaced apart by at least 2 hours.

Ibandronate: Formation of non-absorbable complexes

Indinavir: Magnesium may decrease the absorption of indinavir.

Levofloxacin: Formation of non-absorbable complexes

Lomefloxacin: Formation of non-absorbable complexes

Methacycline: Formation of non-absorbable complexes

Minocycline: Formation of non-absorbable complexes

Moxifloxacin: Formation of non-absorbable complexes

Norfloxacin: Formation of non-absorbable complexes

Ofloxacin: Formation of non-absorbable complexes

Oxytetracycline: Formation of non-absorbable complexes

Pefloxacin: Formation of non-absorbable complexes

Polystyrene sulfonate: Risk of alkalosis in renal impairment

Quinidine: Magnesium antacids may decrease the absorption of quindine.

Quinidine barbiturate: The antiacid decreases the absorption of quinidine

Risedronate: Formation of non-absorbable complexes

Rosuvastatin: Magnesium-containing antacids may decrease the absorption of rosuvastatin.

Temafloxacin: Formation of non-absorbable complexes

Tetracycline: Formation of non-absorbable complexes

Trovafloxacin: Formation of non-absorbable complexes

Terms of Use